What If Swine Flu Cases Have Peaked?
It is an audacious statement, but Sir Liam Donaldson, Chief Medical Officer of the UK, believes that swine flu cases may have peaked at about 110,000. He sees evidence that the number of people…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 341Fighting Swine Flu The Wal-Mart Way (WMT, AZN, GSK, NOVN, SNY)
You can just see the TV advertisements now… Wal-Mart and Uncle Sam are “rolling back” swine flu. The retailer is in talks with federal officials about possibly putting vaccination sites in its stores this…
Swine Flu Research Causes 165% Surge In Inovio (INO)
As first reported at our affiliate site BioHealth Investor: Inovio Biomedical Corporation (NYSE Amex: INO) has been higher by over 160% for most of the morning. Investors are following the news reports this morning that…
Europe Steps Up Timetable On Swine Flu Vaccines (VICL, NVAX, BCRX)
Shares of vaccine makers including Vical Inc. ((Nasdaq: VICL), Novavax Inc. (Nasdaq: NVAX) and BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) all are up strongly Monday after Europe’s version of the FDA decided to fast-track swine…
24/7 Wall St. TV: Funding Healthcare, Taxing The Obese
The Administration and Congress are looking for ways to close the funding gap for the $1 trillion national health care overhaul. The hospital industry has already agreed to $155 billion in concessions and pharma…
Rigel’s Troubled Arthritis Treatment
Biotehc firm Rigel’s (RIGL) rheumatoid arthritis drug candidate R788 did not meet its primary endpoint in Phase IIb clinical trial, probably putting in question the company’s goal of securing a R788 partner by the…
Bristol-Myers Gets Key Assets With A Medarex Deal (BMY, MEDX, ABT, JNJ, AMGN, WYE)
Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get a great deal beyond the cancer monoclonal antibody that developed together. The Medarex pipeline has…
Drug Firms Look For Big Profits In Swine Flu Treatments
The swine flue is apparently more dangerous that the garden variety of flu that has been part of the world health picture for several decades. It is more likely to cause pneumonia and other…
The Next Blockbuster Drugs: A $170 Billion Opportunity
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help from Thomson…
A World With 1.3 Billion Old People By 2040
The world will have 1.3 billion people over 65 by 2040, according to a new report from the US Census Bureau. According to Reuters, “An aging population will push up pension and health care…
IPO FILING: Addus HomeCare Corporation (ADUS)
Addus HomeCare Corporation has filed to come public via an initial public offering. The company has taken the “ADUS” as the tentative ticker for a NASDAQ listing and the filing shows an equity offering…
CBO Pans Healthcare Plan
Obama’s health care received perhaps its harshest criticism to-date Thursday, after the nonpartisan Congressional Budget Office said it will “significantly” expand public spending in an already unbalanced budget. The testimony puts serious doubt in…
Health Net’s Major Loss.. Likely Lesson For All Insurers (HNT, HUM, AET, UNH)
Health Net Inc. (NYSE: HNT) is one of today’s worse performers on the heels of losing its Pentagon health insurance contract. The Pentagon picked Aetna Inc. (NYSE: AET) and UnitedHealth Group Inc. (NYSE: UNH)…
Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)
Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed information and analysis at BioHealthInvestor.com: New short-interest data suggest traders are now increasing their…
A Tax On The “Rich” To Remake American Healthcare
Having money is not what it used to be. According to several media reports, the billionaire mayor of New York City, Michael Bloomberg, lost millions of dollars in the market downturn. He has apparently…